ACE and Duchenne muscular dystrophy: Importantly, ACE inhibitors are elective drugs in the management of cardiomyopathy and late heart failure of DMD patients, while preclinical studies in mdx mice underlined a prominent role of ANG II-related pathway in early inflammation and in late fibrosis in skeletal muscle (4, 18).